Koers Clearmind Medicine Inc. Canadian Securities Exchange
Aandelen
CMND
CA1850534027
Biotechnologie & Medisch Onderzoek
Omzet 2022 | - | Omzet 2023 | - | Marktkapitalisatie | 1,78 mln. 2,44 mln. 1,66 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -9 mln. -12,32 mln. -8,35 mln. | Nettowinst (verlies) 2023 | -8 mln. -10,95 mln. -7,43 mln. | EV/omzet 2022 | - |
Nettoliquiditeiten 2022 | 388K 531K 360K | Nettoliquiditeiten 2023 | 5,51 mln. 7,55 mln. 5,12 mln. | EV/omzet 2023 | - |
K/w-verhouding 2022 |
-1,09
x | K/w-verhouding 2023 |
-0,09
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 100% |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+23,37% | 46,71 mld. | |
+48,83% | 41,8 mld. | |
-0,94% | 41,52 mld. | |
-5,86% | 29,55 mld. | |
+11,29% | 25,78 mld. | |
-20,92% | 19,26 mld. | |
+3,20% | 12,14 mld. | |
-2,67% | 12,08 mld. | |
+30,23% | 11,98 mld. |